M&A deals, company strategies, pipeline updates and more
Follow our coverage of the 2019 J.P. Morgan Healthcare Conference in San Francisco
Last week, Allergan's CEO told investors that Botox “continues to remain very strong” in migraine despite the arrival of three new CGRP drugs. But how…
In a first for pharma and healthcare agencies, McCann Health has hired a global creative chief directly from a large consumer agency.
The balance of spending in medical marketing has shifted from almost 90% directed at healthcare professionals 20 years ago, to just 70%.
Johnson & Johnson knows the immunology market is crowded. But that doesn’t mean it doesn’t still see tons of opportunity there.
Investors had been worried that growth for Regeneron’s Eylea was slowing down, but Monday the company batted away those fears.
Eli Lilly is the first pharma to add pricing information to its DTC TV advertising in a commercial for Trulicity this week, with more on the way.
Alexion aims to transform from an ultrarare-disease company to a rare-disease company—and to make that happen, its pricing has to change.
With key commercial cog Mark Mallon bound for Ironwood’s CEO spot, AstraZeneca is reorganizing into two new R&D and commercial lineups.
Matt Eastwood, McCann Health’s new global chief creative officer, fills a role that's been vacant since July.
The Philadelphia city council paused its proposal to regulate pharmaceutical sales reps at the final meeting of the year but will take it up in 2019.